The team, led by Nichola Garbett, Ph.D., published its findings online today in PLOS ONE.
"We have been able to demonstrate a more convenient, less intrusive test for detecting and staging cervical cancer," Garbett said. "Additionally, other research has shown that we are able to demonstrate if the current treatment is effective so that clinicians will be able to better tailor care for each patient."
Nichola C. Garbett, Michael L. Merchant, C. William Helm, Alfred B. Jenson, Jon B. Klein, Jonathan B. Chaires. Detection of Cervical Cancer Biomarker Patterns in Blood Plasma and Urine by Differential Scanning Calorimetry and Mass Spectrometry. PLoS ONE, 2014; 9 (1): e84710 DOI: 10.1371/journal.pone.0084710Number